Articles

Efficacy of first-line treatments for multiple myeloma patients not eligible for stem cell transplantation: a network meta-analysis

Erasmus School of Health Policy & Management, Institute for Medical Technology Assessment, Erasmus University Rotterdam;Comprehensive Cancer Organisation, Utrecht
Erasmus MC Cancer Institute, Rotterdam
Erasmus School of Health Policy & Management, Institute for Medical Technology Assessment, Erasmus University Rotterdam
Erasmus School of Health Policy & Management, Institute for Medical Technology Assessment, Erasmus University Rotterdam;Comprehensive Cancer Organisation, Utrecht
Erasmus MC Cancer Institute, Rotterdam
Department of Hematology, Amsterdam UMC, the Netherlands
Vol. 104 No. 5 (2019): May, 2019 https://doi.org/10.3324/haematol.2018.206912